Linda F. Powers

National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC.

H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL.

Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman in March 2002 and is headquartered in Salt Lake City, UT.

Vet-Stem, Inc. develops and tests veterinary pharmaceuticals. The firm develops therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in animals. It offers veterinarian consultation, collection and shipping system, training materials, protocols and information for utilization of regenerative cell therapy, and literature references and background information services .The company was founded by Robert J. Harman and Michael Dale in 2002 and is headquartered in Poway, CA.

Toucan Capital Fund II LP, an SBIC fund, seeks investment opportunities in companies located in the United States, primarily in the Mid Atlantic region. The fund focuses on companies operating in the fields of life science and advanced technology. It provides equity financing for seed, early and later stage capital requirements with an investment size of $0.1 and $5 million. It acts as a lead investor, considers co-investments and makes follow-on investments.

Toucan Capital Fund III LP seeks investment opportunities in companies located in the United States, primarily in the Mid Atlantic region. The fund focuses on companies operating in the fields of life science and advanced technology. It provides equity financing for seed, early and later stage capital requirements with an investment size of $0.1 and $5 million. It acts as a lead investor, considers co-investments and makes follow-on investments.